Literature DB >> 3098664

Orthotopic liver transplantation for type I Crigler-Najjar syndrome.

S S Kaufman, R P Wood, B W Shaw, R S Markin, P Rosenthal, B Gridelli, J A Vanderhoof.   

Abstract

A neurologically normal 3-year-old girl with Type I Crigler-Najjar syndrome was successfully treated with orthotopic liver transplantation. Preoperative serum bilirubin concentrations as high as 31 mg per dl were not diminished with phenobarbital or phototherapy. Bilirubin fractionation of duodenal bile prior to transplantation revealed 87.1% unconjugated bilirubin and 12.9% monoconjugates as determined by alkaline methanolysis-high-performance liquid chromatography. Postoperatively, the serum bilirubin concentration quickly fell to normal. Uridine diphosphate glucuronyl transferase activity in the recipient liver was not detectable. The gallbladder bile bilirubin concentration of 23.9 mg per dl was less than 15% of previously reported normal values. Since devastating kernicteric brain injury is the invariable outcome of Type I Crigler-Najjar syndrome, liver transplantation should be performed when phototherapy cannot maintain the serum bilirubin concentration at an unequivocally safe level.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098664     DOI: 10.1002/hep.1840060606

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Successful treatment of homozygous protein C deficiency by hepatic transplantation.

Authors:  J F Casella; J H Lewis; F A Bontempo; B J Zitelli; H Markel; T E Starzl
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

2.  Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I.

Authors:  M Rela; P Muiesan; H Vilca-Melendez; A Dhawan; A Baker; G Mieli-Vergani; N D Heaton
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

3.  Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants.

Authors:  C E Broelsch; J C Emond; P F Whitington; J R Thistlethwaite; A L Baker; J L Lichtor
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

Review 4.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 5.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 6.  Organ transplantation for inherited metabolic disease.

Authors:  D A Kelly
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

Review 7.  Liver transplantation: current concepts.

Authors:  W J Wall
Journal:  CMAJ       Date:  1988-07-01       Impact factor: 8.262

8.  Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.

Authors:  P Labrune; A Myara; M Hadchouel; F Ronchi; O Bernard; F Trivin; N R Chowdhury; J R Chowdhury; A Munnich; M Odièvre
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

9.  Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.

Authors:  L T Erps; J K Ritter; J H Hersh; D Blossom; N C Martin; I S Owens
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

Review 10.  Treatment of inherited metabolic disorders by liver transplantation.

Authors:  M Burdelski; B Rodeck; A Latta; K Latta; J Brodehl; B Ringe; R Pichlmayr
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.